Why separating these matters
Most guidance given to patients starting antibiotics treats all GI side effects as a single category: "take with food, drink plenty of water, and it should pass." This covers the simplest cases. It leaves patients unprepared for the fact that diarrhoea and bloating that begin during a course may continue for weeks after it ends — not because the antibiotic is still in their system, but because the microbiome disruption persists.
Nausea — the direct irritation mechanism
Most antibiotics cause some degree of direct mucosal irritation — the chemical compound contacts the epithelial lining in the stomach and small intestine.
Macrolides (azithromycin, clarithromycin, erythromycin) have an additional mechanism: they activate motilin receptors in the stomach and small intestine, causing accelerated, uncoordinated contractions — producing cramping and nausea within 1–2 hours of the first dose.
Metronidazole causes severe nausea through direct mucosal irritation, a metallic taste that amplifies the nausea signal, and CNS effects at higher doses. This is why H. pylori eradication regimens including metronidazole are consistently described as the worst antibiotic experience patients have had.
Diarrhoea — the microbiome mechanism
Antibiotic-associated diarrhoea (AAD) occurs in approximately 5–35% of patients depending on the antibiotic class. The mechanism is primarily microbiome collapse.
Commensal bacteria in the colon ferment unabsorbed carbohydrates, absorb water, produce SCFAs, and regulate colonic transit speed. When broad-spectrum antibiotics deplete these populations, colonic transit accelerates and unfermented carbohydrates cause osmotic diarrhoea.
When commensal bacteria are depleted, C. difficile can proliferate and produce toxins A and B that destroy the colonic epithelium. The distinguishing features are lower abdominal cramping (not upper), watery diarrhoea beginning on or after day 3, and in more severe cases fever and systemic illness. Unlike standard AAD, C. diff does not resolve without specific antibiotic treatment (typically fidaxomicin or vancomycin). Diarrhoea persisting more than two weeks after completing antibiotics, or associated with cramping, fever, or blood, requires medical evaluation and stool testing.
Bloating — the dysbiosis fermentation mechanism
Post-antibiotic bloating is driven by the disrupted microbiome community — with SCFA-producing commensals depleted and gas-producing gram-negative organisms relatively elevated.
Dietary carbohydrates that were previously fermented into SCFAs by Bifidobacterium and Faecalibacterium prausnitzii are now processed differently, producing more hydrogen, methane, and CO₂ gas from the same dietary input.
This bloating often persists for weeks after the course, because it reflects microbiome composition rather than drug presence. Probiotics and prebiotic fibre are the most evidence-based interventions — reseeding SCFA-producers and providing the substrate they need to rebuild populations.
The H. pylori eradication patient — all three at once
Triple therapy for H. pylori eradication (amoxicillin + clarithromycin/metronidazole + PPI, typically 10–14 days) activates all three mechanisms simultaneously: direct mucosal irritation from multiple drugs, microbiome collapse from broad-spectrum coverage, and dysbiosis fermentation immediately after. This is why H. pylori eradication is the most challenging antibiotic experience for the gut — and why mucosal support during and after the course matters most for this patient.
The microbiome symptoms end. The microbiome recovery does not happen automatically — it requires active support for weeks to months after the course concludes.
References
- Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clinical Infectious Diseases. 2008;46(S1):S12–18. PMID 18177217. Clinical features distinguishing C. diff colitis from standard antibiotic-associated diarrhoea — the basis for the warning signs in this article.
- Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. PNAS. 2011;108(S1):4554–4561. PMID 20847294. Longitudinal study showing incomplete microbiome recovery months after antibiotics — basis for the statement that recovery is not automatic.
- Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380:1158–1165. PMID 30699316. H. pylori eradication therapy context — the clinical scenario most likely to produce all three antibiotic GI mechanisms simultaneously.